Paper855997
Cefoxitin: clinical evaluation in thirty-eight patients.
Heseltine PN and 3 others. Antimicrob Agents Chemother, 1977. Cited by 49 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cefoxitin: clinical evaluation in thirty-eight patients. Papers, record 855997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/855997
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Infections | Major topic |
| Cefoxitin | Major topic |
| Cephalosporins | Major topic |
| Adult | |
| Aged | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Male | |
| Microbial Sensitivity Tests | |
| Middle Aged | |
| Peritonitis | |
| Pneumonia | |
| Urinary Tract Infections |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,830,485 | Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15830485 | PubMed |
| 2 | 15,830,475 | Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15830475 | PubMed |
| 3 | 15,828,188 | Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15828188 | PubMed |
| 4 | 4,202,265 | Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin. | Br Med J | 1973 | https://conductscience.org/library/papers/4202265 | PubMed |
| 5 | 4,599,124 | Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4599124 | PubMed |
| 6 | 5,053 | Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/5053 | PubMed |
| 7 | 4,840,447 | Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4840447 | PubMed |
| 8 | 4,790,596 | Cephalosporinase activity in Bacteroides fragilis. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4790596 | PubMed |
| 9 | 4,791,486 | Clinical studies of cefazolin and comparison with other cephalosporins. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4791486 | PubMed |
| 10 | 4,915,151 | The cephalosporins. Microbiological, chemical, and pharmacological properties and use in chemotherapy of infection. | Ann Intern Med | 1970 | https://conductscience.org/library/papers/4915151 | PubMed |
| 11 | 804,023 | Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. | J Infect Dis | 1975 | https://conductscience.org/library/papers/804023 | PubMed |
| 12 | 949,175 | Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/949175 | PubMed |
| 13 | 1,263,595 | The in vitro spectrum of the cephalosporins. | Mayo Clin Proc | 1976 | https://conductscience.org/library/papers/1263595 | PubMed |
| 14 | 1,267,443 | Comparison of phlebitis produced by cephapirin and cephalothin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1267443 | PubMed |
| 15 | 1,244,540 | Letter: Best's biliary flush. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1244540 | PubMed |
| 16 | 1,137,364 | Susceptibility of anaerobes to cefoxitin and other cephalosporins. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1137364 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,175,707 | Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study. | Ann Intensive Care | 2022 | https://conductscience.org/library/papers/36175707 | PubMed |
| 7,396,456 | Clinical and pharmacokinetic evaluation of parental cefoxitin in infants and children. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7396456 | PubMed |
| 7,103,449 | Penetration of cefoxitin into cerebrospinal fluid of infants and children with bacterial meningitis. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7103449 | PubMed |
| 6,372,916 | Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients? | Bull N Y Acad Med | 1984 | https://conductscience.org/library/papers/6372916 | PubMed |
| 6,360,636 | Antimicrobial drugs used in the management of anaerobic infections in children. | Drugs | 1983 | https://conductscience.org/library/papers/6360636 | PubMed |
| 3,319,501 | Treatment of respiratory tract infections with cephalosporin antibiotics. | Drugs | 1987 | https://conductscience.org/library/papers/3319501 | PubMed |
| 3,045,147 | Susceptibility testing of anaerobic bacteria. | J Clin Microbiol | 1988 | https://conductscience.org/library/papers/3045147 | PubMed |
| 2,327,757 | Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327757 | PubMed |
| 1,295,755 | Clinical relevance of antimicrobial susceptibility testing. | Eur J Clin Microbiol Infect Dis | 1992 | https://conductscience.org/library/papers/1295755 | PubMed |
| 507,792 | Anaerobic infection in cancer patients: comparative evaluation of clindamycin and cefoxitin. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/507792 | PubMed |
| 485,129 | Clinical and bacteriological evaluation of cefoxitin therapy in children. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/485129 | PubMed |
| 369,806 | Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. | Drugs | 1979 | https://conductscience.org/library/papers/369806 | PubMed |
| 348,096 | Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/348096 | PubMed |
| 335,968 | Results of a clinical trial of cefoxitin, a new cephamycin antibiotic. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/335968 | PubMed |
| 122,524 | Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/122524 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/855997
GET https://conductscience.org/api/papers/v1/855997/authors